According to Ampio Pharmaceuticals's latest financial reports the company's total assets are $5.73 M. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $13.58 M | -65% |
2021-12-31 | $38.82 M | 69.7% |
2020-12-31 | $22.87 M | 63.4% |
2019-12-31 | $14 M | -0.21% |
2018-12-31 | $14.03 M | -8.39% |
2017-12-31 | $15.31 M | 12.64% |
2016-12-31 | $13.59 M | -73.03% |
2015-12-31 | $50.41 M | -28.25% |
2014-12-31 | $70.26 M | 95.09% |
2013-12-31 | $36.01 M | 39.35% |
2012-12-31 | $25.84 M | 32.67% |
2011-12-31 | $19.48 M | 2541.62% |
2010-12-31 | $0.73 M | 754.8% |
2009-12-31 | $0.08 M | 161.96% |
2008-12-31 | $0.03 M | 3.74% |
2007-12-31 | $0.03 M | 5.29% |
2006-12-31 | $0.03 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $167.55 B | 2,921,064.57% | ๐บ๐ธ USA |
Pfizer PFE | $226.50 B | 3,948,662.20% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $73.21 B | 1,276,294.70% | ๐บ๐ธ USA |
Regeneron Pharmaceuticals REGN | $33.08 B | 576,611.99% | ๐บ๐ธ USA |
Rigel Pharmaceuticals RIGL | $0.11 B | 1,943.67% | ๐บ๐ธ USA |
Flexion Therapeutics
FLXN | N/A | N/A | ๐บ๐ธ USA |
Aerie Pharmaceuticals AERI | $0.37 B | 6,447.94% | ๐บ๐ธ USA |